Alzheimer's Archives

News and Trends 12 Sep 2022

Liquid-interface assisted SERS could lead to earlier detection of Alzheimer’s

In a new publication in Opto-Electronic Advances, Japanese researchers discussed label-free trace detection of bio-molecules by liquid-interface assisted surface-enhanced Raman scattering (SERS) using a microfluidic chip. SERS has attracted attention in biotechnology. This is due to its high sensitivity to localized surface plasmon resonance of nanostructured metals. Trace detection of bio-molecules with large molecular weight […]

September 12, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Sep 2022

Alzinova announces new positive safety review for Alzheimer’s study

Alzinova AB says a second external safety review has been carried out of its clinical phase 1b study. This resulted in a positive assessment to continue the study as planned. Behind the review is an independent expert group, Data and Safety Monitoring Board (DSMB), which continuously reviews the study. Based on the patients included in […]

September 7, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Sep 2022

Proxidrugs: a new tool to fight pathogens?

Scientists at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP in Germany are working with partners to develop a new drug class. Proxidrugs (or proximity-inducing drugs) utilize cells’ waste disposal system as potential new treatments for cancer, infections and Alzheimer’s disease. Aimo Kannt, head of drug discovery and preclinical research at Fraunhofer ITMP in […]

September 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 28 Jun 2022

Biogen, citing insurance challenges, shutters one of its Aduhelm studies

A company says it was forced to end an observational trial of Alzheimer’s drug, Aduhelm, after a ruling by US federal insurance program, Medicare. Biogen said a recent coverage decision by Medicare has forced it to abandon the trial of the drug after enrolling just 29 participants. The company said it made the decision to […]

June 28, 2022 - 3 minutesmins - By Liza Laws

News and Trends 20 Jun 2022

Boost for dementia gene-based therapies

The Cell and Gene Therapy Catapult (CGT Catapult) and the UK Dementia Research Institute (UK DRI) have announced a collaboration to accelerate the clinical development of adeno-associated virus (AAV) based gene therapies for dementia. Since 2015, dementia has been one of the leading causes of mortality in the UK. While new and improved treatments for […]

June 20, 2022 - 3 minutesmins - By Jim Cornall

Discovering New Therapeutic Targets for Alzheimer’s Disease

Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with a high risk of failure. Strategic partnerships can help biotech companies manage costs and access the latest technologies to drive innovation and advance novel therapy ideas. A serious unmet medical need Finding treatments for neurodegenerative […]

September 22, 2021 - 7 minutesmins - By Julia Kaiser

News and Trends 2 Sep 2021

AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research

An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II results this week, raising tentative hopes for the field of treatments targeting the protein tau. For decades, the major culprit responsible for Alzheimer’s disease was suggested to be the buildup of a protein called amyloid-beta in the brain. Blocking this […]

September 2, 2021 - 5 minutesmins - By Jonathan Smith

danish biotech neurodegenerative alzheimers 1

News and Trends 20 Jul 2021

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

Muna Therapeutics debuted with the Danish biotech sector’s biggest-ever Series A round earlier this month. This showcases the rapid growth taking place in the biotech industry in the Nordic region. Muna Therapeutics’ €62M ($73M) investment was co-led by the Danish investor Novo Holdings through its early-stage arm Novo Seeds. The startup was first set up […]

July 20, 2021 - 4 minutesmins - By Victor Kotsev

Best in Biotech 30 Jun 2021

Scotland’s Top 10 Biotech Companies to Watch Out For

Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial biotech. Let’s pick up the bagpipes as we tour the top 10 biotech companies in Scotland. Scotland is the UK’s second-most populous country, boasting picturesque scenery, a rich history, and a strong focus on sustainability. There is a diverse range […]

June 30, 2021 - 11 minutesmins - By Jonathan Smith

News and Trends 17 Jun 2021

FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space

The FDA shocked many life sciences observers by greenlighting Biogen’s treatment candidate for Alzheimer’s last week. Yet, for much of the Alzheimer’s disease community on both sides of the Atlantic, the decision also brings cautious hope. Controversy recently erupted when the FDA conditionally granted accelerated approval to Biogen’s aducanumab, making it the first approved treatment […]

June 17, 2021 - 6 minutesmins - By Victor Kotsev

News and Trends 21 Dec 2020

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation

Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field with a drug that puts brakes on inflammation in the brain. Last week, AB Science reported successful results from a phase IIb/III clinical trial testing its drug masitinib in patients with mild to moderate symptoms of Alzheimer’s. Although the company […]

December 21, 2020 - 5 minutesmins - By Victor Kotsev

Interview 2 Sep 2020

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

For decades, Alzheimer’s disease research focused on a hypothesis that has increasingly been contested. A team of scientists in Slovakia has been swimming against the tide since the beginning, going for an alternative approach that has only recently started gaining recognition. Research in Alzheimer’s disease has recently been plagued by intense disappointment. For over 25 […]

September 2, 2020 - 8 minutesmins - By Farhan Mitha

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Alzheimer’s

Liquid-interface assisted SERS could lead to earlier detection of Alzheimer’s

Alzinova announces new positive safety review for Alzheimer’s study

Proxidrugs: a new tool to fight pathogens?

Biogen, citing insurance challenges, shutters one of its Aduhelm studies

Boost for dementia gene-based therapies

Discovering New Therapeutic Targets for Alzheimer’s Disease

AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

Scotland’s Top 10 Biotech Companies to Watch Out For

FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!